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Abstract:
Background: Acinetobacter is a leading multidrug resistant pathogen in 
hospitals worldwide that has been seen to exhibit periodic surges during 
summer months. However, winter peaks and lack of seasonality have 
also been noted. 
Objectives: To systematically collate and examine the evidence 
describing seasonal patterns in the incidence of Acinetobacter infection in 
hospitalized patients. 
Data sources: MEDLINE/Ovid, EMBASE, Scopus and Web of Science. 
Study eligibility criteria: Longitudinal observational studies investigating 
seasonal variation in the incidence of Acinetobacter infection. 
Participants: Patients receiving hospital care. 
Interventions: Routine hospital care. 
Methods: Systematic review with narrative evidence synthesis structured 
around clinical and methodological heterogeneity and internal validity of 
retrieved studies, seasonal patterns and risk factors detected, and stated 
hypotheses of mechanisms underlying seasonality. To examine 
consistency in reported seasonal patterns across different conditions, 
monthly incidence data were extracted, standardised, weighted and 
presented graphically. 
Results: Twenty-five studies reporting 37006 cases of Acinetobacter 
infection or colonization during 1954 months of follow-up were reviewed. 
Standardised monthly incidence data pooled across studies exhibited a 
global seasonal pattern with an incidence peak in summer/warmer 
months and a trough in winter/colder months. This seasonal pattern 
remained consistent under different weighting schemes accounting for 
study size, length of follow-up and overall quality assessment rating. 
Seasonality persisted in different clinical settings and for different types 
and sources of infection. Nine studies provided consistent evidence of 
temperature-associated variation in Acinetobacter incidence, while there 
were controversial findings regarding other environmental variables. No 
study detected patient-related or clinical practice-related seasonal 
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variation in Acinetobacter incidence. 
Conclusions: Despite substantial clinical and methodological 
heterogeneity in retrieved studies, a consistent global seasonal pattern 
in Acinetobacter infection incidence was evident in this review. This 
merits attention when designing or evaluating infection control 
interventions in hospitals. Future research should focus on elucidating 
driving mechanisms underlying the observed seasonality. 
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22 ABSTRACT
23
24 Background: Acinetobacter is a leading multidrug resistant pathogen in hospitals 
25 worldwide that has been seen to exhibit periodic surges during summer months. 
26 However, winter peaks and lack of seasonality have also been noted.
27 Objectives: To systematically collate and examine the evidence describing seasonal 
28 patterns in the incidence of Acinetobacter infection in hospitalized patients.
29 Data sources: MEDLINE/Ovid, EMBASE, Scopus and Web of Science.
30 Study eligibility criteria: Longitudinal observational studies investigating seasonal 
31 variation in the incidence of Acinetobacter infection.
32 Participants: Patients receiving hospital care.
33 Interventions: Routine hospital care.
34 Methods: Systematic review with narrative evidence synthesis structured around clinical 
35 and methodological heterogeneity and internal validity of retrieved studies, seasonal 
36 patterns and risk factors detected, and stated hypotheses of mechanisms underlying 
37 seasonality. To examine consistency in reported seasonal patterns across different 
38 conditions, monthly incidence data were extracted, standardised, weighted and 
39 presented graphically.
40 Results: Twenty-five studies reporting 37006 cases of Acinetobacter infection or 
41 colonization during 1954 months of follow-up were reviewed. Standardised monthly 
42 incidence data pooled across studies exhibited a global seasonal pattern with an 
43 incidence peak in summer/warmer months and a trough in winter/colder months. This 
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44 seasonal pattern remained consistent under different weighting schemes accounting for 
45 study size, length of follow-up and overall quality assessment rating. Seasonality 
46 persisted in different clinical settings and for different types and sources of infection. 
47 Nine studies provided consistent evidence of temperature-associated variation in 
48 Acinetobacter incidence, while there were controversial findings regarding other 
49 environmental variables. No study detected patient-related or clinical practice-related 
50 seasonal variation in Acinetobacter incidence.
51 Conclusions: Despite substantial clinical and methodological heterogeneity in retrieved 
52 studies, a consistent global seasonal pattern in Acinetobacter infection incidence was 
53 evident in this review. This merits attention when designing or evaluating infection 
54 control interventions in hospitals. Future research should focus on elucidating driving 
55 mechanisms underlying the observed seasonality.
56
57 Key words: 
58 Acinetobacter baumannii; Seasonality; Season; Climate; Healthcare associated infection; 
59 Epidemiology.
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4
60 Introduction
61
62 Acinetobacter species, particularly Acinetobacter baumannii is a leading 
63 multidrug resistant microorganism in hospitals worldwide causing severe nosocomial 
64 infections such as bloodstream infections and ventilator-associated pneumonia [1–3]. 
65 The abilities of the organism to survive in inanimate environments for long times, 
66 rapidly develop antibiotic resistance and spread clonally potentiate the persistence and 
67 transmission of the species in healthcare settings [3,4]. Acinetobacter is also one of the 
68 first nosocomial pathogens that has been reported to exhibit periodic peaks in its 
69 incidence during the summer or warmer months [5]. However, opposite seasonal 
70 occurrence with peaks during winter and lack of seasonality have also been reported 
71 [6,7].  The reasons for this variability remain poorly understood [8]. 
72 This study aims to systematically collate and evaluate the existing evidence 
73 describing seasonal patterns in the incidence of Acinetobacter infection in hospitalized 
74 patients. Moreover, factors found to be associated with seasonal variation and 
75 hypotheses of mechanisms underlying seasonality were recorded. Methods used to 
76 assess seasonality, internal validity and clinical heterogeneity of retrieved studies were 
77 examined.
78
79 Methods
80
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81 This systematic review is PROSPERO-registered (registration number: 
82 CRD42018114547) and complies with the Preferred Reporting Items for Systematic 
83 Reviews and Meta-Analyses (PRISMA) statement [9].
84
85 Search strategy
86 MEDLINE/Ovid, EMBASE, Scopus and Web of Science were searched up until 23 
87 October 2018 for longitudinal observational studies investigating seasonal variation in 
88 the incidence of infections caused by Acinetobacter spp. in hospital settings. The search 
89 was restricted to research articles written in English and published in peer-reviewed 
90 journals. Different combinations of the keywords “Acinetobacter”, “Acinetobacter 
91 baumannii”, “Acinetobacter infections”, “seasonal pattern” and “season*” were used to 
92 retrieve the articles  (detailed in Supplementary Appendix A). Manual checking of  
93 reference lists and citation tracking of included papers in Scopus and Web of Science 
94 were performed.
95
96 Screening and eligibility
97 Duplicate records were removed using the Mendeley reference managing software. 
98 A two-step screening process for eligibility was undertaken. First, one author (AGK) 
99 excluded ineligible studies by screening titles and abstracts. Then, both authors 
100 reviewed independently the full texts of potentially eligible studies for inclusion in the 
101 review. Disagreements were resolved through discussion and consensus. Eligibility was 
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102 assessed by applying the PICOS (population, intervention, comparators/controls, 
103 outcomes and study design) question format [9], as follows:
104 ♣ Population: Patients receiving hospital care.
105 ♣ Intervention: Experimental studies and outbreak reports were excluded from 
106 the review because of possible interference that interventions might have on 
107 transmission dynamics of Acinetobacter spp in routine care settings. 
108 ♣ Comparators/controls: Presence of a control group was not a requirement 
109 for study inclusion.
110 ♣ Outcomes: The outcome of interest was the incidence (expressed as count, 
111 proportion or rate) of hospital-acquired or community-acquired infection, at 
112 any site, that was caused by Acinetobacter species in hospitalized patients. 
113 Studies not distinguishing colonization from infection were included. 
114 ♣ Study design: Observational longitudinal studies reporting the incidence of 
115 Acinetobacter spp. infections, with at least 12 consecutive months of follow-
116 up to cover all seasons, were included. 
117 Studies that did not fulfil the eligibility criteria were excluded and reasons stated 
118 (Supplementary Appendix B).
119
120 Data extraction
121 Information extracted from retrieved studies included: identification data (first 
122 author, title and year of publication); study design, length of follow-up; geographical 
123 location and data source; type or specialty of patients; total number of infections; 
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124 source of infection (community- or hospital- acquired); type/site of infection; and 
125 member of the Acinetobacter species.  Additionally, factors found to be associated with 
126 and factors found not to be associated with seasonal variation, and hypotheses on 
127 mechanisms of seasonality (argued for or against by the authors) were recorded. Where 
128 available, monthly or quarterly incidence counts, proportions or rates of Acinetobacter 
129 infection were extracted. Data presented in graphical format were retrieved using Plot 
130 Digitizer version 2.6.6 (http://plotdigitizer.sourceforge.net/).  Data were summarized in 
131 a Google spreadsheet by one author (AGK) and crosschecked by the other author (EIK).
132
133 Evidence synthesis
134 Findings were summarised in a narrative synthesis structured around clinical 
135 heterogeneity, methodological characteristics and quality assessment of retrieved 
136 studies, seasonal patterns detected, risk factors and hypotheses of mechanisms 
137 underlying seasonality. To describe and assess consistency in reported seasonal 
138 patterns, monthly infection incidence data were standardised using z-scores on a study-
139 by-study basis to bring different units of measurement into one common scale across 
140 studies. Data from studies in the southern hemisphere were adjusted by six months. The 
141 average of standardised monthly incidence data across all studies was then plotted. 
142 Different weighting schemes were used to account for length of follow-up, study size 
143 and overall quality rating. Stratified graphs of standardized data were used to examine 
144 consistency in seasonality for different types and sources of infection and between 
145 different clinical settings. 
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146
147 Quality appraisal
148 Internal validity of each study was assessed by one author (EIK) based on the 
149 Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [10]. 
150 Appendix C details how this assessment was carried out. We also assessed 
151 methodological heterogeneity in relation to whether studies were performed with the 
152 specific objective of assessing seasonality, what their scale and coverage were, and 
153 which statistical methods were used to assess seasonality. For the latter, the statistical 
154 method was classified into one of four distinct types [11]: (a) graphical inspection of 
155 incidence data over time; (b) direct comparison of incidence between discrete calendar 
156 periods; (c) geometrical model assuming a sinusoidal cyclic pattern, and (d) generalised 
157 linear and/or time series regression model.
158
159 Results
160
161 Setting and clinical heterogeneity of retrieved studies
162 The search identified 294 non-duplicate publications, of which 25 met the 
163 eligibility criteria and were reviewed (Figure 1).  Main characteristics of the studies are 
164 summarised in Table I. The studies were published from 1979 to 2018 and 15 (60%) 
165 appeared over the last 10 years.  Most studies (n=18; 72%) were conducted in countries 
166 in the Northern Hemisphere (8 in North America, 6 in Europe and 4 in Asia), and only a 
167 quarter (n=6; 24%) were in the Southern Hemisphere (5 in Brazil and 1 in Australia). One 
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168 study was multi-national and included countries in both North and South America. Most 
169 (n=19; 76%) were performed at a single institution, while 6 (24%) were multi-centre 
170 studies. The majority of studies (n=20; 80%) were conducted hospital-wide, while a fifth 
171 of the investigations (n=5; 20%) were restricted in ICUs. There was no age restriction in 
172 11 (44%) studies, 3 (12%) studies examined only adult patients and 11 (44%) studies did 
173 not report patient demographics. 
174 Overall, 37006 cases of Acinetobacter infection during 1954 months of follow-up 
175 were reported. Colonization was not distinguished from infection in 11 (44%) reports, 
176 while 13 (52%) studies reported infection only and 1 (4%) study examined colonization 
177 only. Hospital-acquired cases were not distinguished from community-onset cases in 12 
178 (48%) occasions, while 10 (40%) studies examined hospital-acquired cases only, 1 (4%) 
179 included community-onset cases only and 2 (8%) studies contrasted between hospital-
180 acquired and community-onset cases. In relation to infection type, 13 studies (52%) 
181 reported all types of infections combined, while 11 (44%) studies looked at bacteraemia 
182 only and 1 (4%) investigated pneumonia only. 
183
184 Methodological characteristics and quality assessment 
185 Retrieved studies were case-series (16/25; 64%) or cohort studies (9/25; 36%) 
186 that examined longitudinally the incidence of Acinetobacter infection based on routine 
187 clinical cultures. Most studies collected data retrospectively (n=15; 60%). There were 15 
188 (60%) studies performed with the specific objective of assessing seasonality and the 
189 remaining 10 studies (40%) assessed seasonal occurrence as a secondary objective. To 
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190 assess seasonality, the authors relied mostly on graphical inspections of disease 
191 incidence over time (n=9; 36%) or direct comparison of incidence data between discrete 
192 calendar periods (n=11; 44%). One study used a geometrical model and 4 (16%) studies 
193 utilized a generalised linear model. Using the Quality Assessment Tool for Observational 
194 Studies, the average quality score of included studies was 79% (SD 13.8%; range 45%-
195 100%) and only 4 studies (16%) obtained a rating below 70% (Table C2, supplementary 
196 Appendix C).
197
198 Global seasonal patterns
199 Seasonal variation in Acinetobacter infections was reported in 18/25 (72%) studies; 
200 whereas 4 (16%) concluded absence of seasonality and 3 (12%) studies were 
201 inconclusive. Seasonality was concluded in 13 of the 15 (87%) studies that assessed it as 
202 a primary objective and in 5 of the 10 studies (50%) that looked at seasonality as a 
203 secondary objective. 
204 All but four studies [8,12–14] reported monthly incidence data in tables and/or 
205 graphs and we extracted 27 series of monthly incidence data from 21/25 (84%) studies 
206 (Table II). Extracted monthly incidence of Acinetobacter infections peaked in the 
207 summer in 12/21 (57.1%) studies, spring in 2/21 (9.5%) studies, autumn in 2/21 (9.5%) 
208 studies, and in the winter in 1/21 (4.8%) study. Differential seasonal variation was noted 
209 in 4/21 (19%) studies in relation to source of infection (summer peak for community-
210 onset infections vs. winter peak for hospital-acquired infections) [15], antimicrobial 
211 resistance (summer peak for non-MDR isolates vs. winter peak for MDR) [7], clinical 
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212 setting (summer peak in wards vs. autumn peak in ICUs) [16], or location (winter peak in 
213 Latin America vs autumn peak in Canada and USA) [17].
214 When monthly incidence data were standardised and pooled across studies, a 
215 clear seasonal pattern in Acinetobacter incidence with a peak in summer/warmer 
216 months and a trough in winter/colder months was evident. This remained consistent 
217 under different weights to account for length of follow-up, number of infections and 
218 quality rating of the studies (Figure 2, panel a).  The same seasonal pattern persisted 
219 when we examined pooled standardised data in relation to seasonality objective 
220 (primary v. secondary), clinical setting (hospital-wide v. ICU), continent where the 
221 studies were performed, infection origin (hospital-acquired v. community-onset), 
222 infection type (any infection v. bacteraemia only), infection status (colonization or 
223 infection v. infection only), and Acinetobacter group (Figure 2, panels b-h).
224
225 Factors associated with seasonal variation
226 Ten (40%) studies examined the relation to weather parameters (ambient 
227 temperature, relative humidity and precipitation or rainfall) [7,8,12,13,15,18–22]. Three 
228 of these additionally looked at or controlled for patient-related risk factors and/or 
229 clinical practice indicators [12,21,22]. To this end, most studies (7/10; 70%) relied on 
230 multivariable generalized linear models (Poisson [8,13,19,20], negative binomial [22] or 
231 logistic [12,21] regression), while the remaining 3 studies used bivariate correlation 
232 coefficients [7,15,18]. 
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233 All nine studies that examined ambient temperature found a positive association 
234 with Acinetobacter incidence [7,8,12,13,15,19–22]. Of note, one study was conducted 
235 exclusively in ICUs [22] and another found that temperature-associated variation in 
236 Acinetobacter infections persisted in the subgroup of patients admitted to ICUs [21], 
237 which were units with climate control. In contrast, of the 5 studies examining relative 
238 humidity, 4 did not find an association with Acinetobacter incidence [8,13,19,21] and 1 
239 noted a negative association [12]. Results were more variable regarding precipitation, 
240 which was examined in 3 studies and was seen to exhibit negative [8], positive [18] or 
241 no correlation [19] with Acinetobacter incidence. 
242 All three studies that examined patient-related and/or clinical practice-related 
243 risk factors noted lack of association with Acinetobacter incidence. Factors studied were 
244 patient age and sex [12], ICU admission [12,21], Charslon comorbidity index [21], length 
245 of stay or time at risk [12,22], device utilization indices [22], size and type of ICU or 
246 hospital [22], and number of pathogens isolated in the previous month [22]. In addition, 
247 Acinetobacter occurrence was measured as an incidence density rate in 4 studies, using 
248 patient-days [22–24] or device-days [25] in the denominator thereby controlling for 
249 fluctuations in admissions, length of stay and intensity of device use. Moreover, one 
250 study examined the molecular heterogeneity of isolates and established that the 
251 seasonal increase in A. baumannii was not due to clonal dissemination of a single strain 
252 [26].
253
254 Hypotheses of underlying mechanisms
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255 Reviewed studies considered several explanatory hypotheses of mechanisms 
256 underlying the seasonality of Acinetobacter infections. Several authors raised the 
257 possibility of community-associated origins related to increased bacterial growth 
258 [15,19,27] and/or survival in environmental reservoirs [8,12,13,21] outside the hospital 
259 setting in higher temperatures. These, in turn, was hypothesized to lead to increased 
260 colonization of humans and increased inflow of Acinetobacter carried by patients and 
261 healthcare workers into hospitals during warmer months [8,12,13,19].  
262 The possibility that higher temperatures may modulate the virulence of 
263 Acinetobacter via regulating the lipid A moiety of lipopolysaccharide in its outer 
264 membrane, thereby contributing to increases in infection occurrence in warmer periods, 
265 was also considered [19].  Others suggested that increased ambient temperature may 
266 promote a biofilm "bloom" of Acinetobacter species in hospital tap water which, 
267 similarly to Pseudomonas aeruginosa, may be related to increased isolation from 
268 standing tap water in patient rooms and higher fecal carriage of healthy adults during 
269 the summer months [20,25]. Another suggestion was that the photoperiod (dark-light 
270 cycles) and not temperature per se might contribute to seasonality because host 
271 susceptibility may depend on the photoperiod and mediated by the length of daily 
272 melatonin pulse and a range of other physiologic parameters [22].
273 Stated hypotheses also acknowledged a potential role of non-weather-related 
274 seasonal factors including understaffing due to summer vacations that may lead to 
275 higher workload and/or lower adherence to infection control measures [8,27], intern 
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276 inexperience with infection control methods and obtaining clinical cultures at different 
277 frequencies in summer [19].
278
279 Discussion
280
281 Our evidence synthesis suggests that the incidence of Acinetobacter infection in 
282 hospitalised patients is characterised by a global seasonal pattern with a peak in 
283 summer/warmer months and a trough in winter/colder months. In our descriptive 
284 graphical assessment, the seasonal pattern remained robust when we gave more weight 
285 to studies with greater follow-up times (as repetition over several years is more likely to 
286 reflect true seasonality), those with larger effective sample size (which avoid potential 
287 masking of temporal patterns because of recording few infections) or those with higher 
288 quality ratings. Moreover, the same seasonal pattern was seen irrespective of whether 
289 the studies addressed seasonality as primary or secondary objective, whether infection 
290 onset was hospital-associated or community-associated, whether the investigation was 
291 performed in ICUs or hospital-wide, whether reporting was restricted to infections or 
292 included colonizations, and whether studies reported A. baumannii or other members of 
293 the species. Therefore, the phenomenon of seasonality in the occurrence of 
294 Acinetobacter infection in hospitalized patients appears to be a robust finding that 
295 merits attention when designing or evaluating strategies for infection prevention and 
296 control in hospitals.
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297 This global seasonal pattern does not seem to relate simply to seasonal variation 
298 in admission times or hospital crowding or susceptibility of the patient population, and 
299 our results show that the mechanisms underlying seasonality remain largely obscure.  
300 We identified consistent evidence of temperature-associated variation in Acinetobacter 
301 incidence in all studies that examined this possibility by incorporating measurements of 
302 ambient temperature in their analysis [7,8,12,13,15,19–22]; whereas we noted 
303 inconsistent findings regarding other weather parameters. Consequently, temperature-
304 driven considerations pointing mostly to community-associated origins of the seasonal 
305 surges in Acinetobacter infections within hospitals were most dominant in forming 
306 hypotheses on mechanisms for seasonality in reviewed studies.  
307 The most common causal hypothesis proposed that higher temperature 
308 promotes bacterial growth, environmental reservoirs, virulence and/or biofilm 
309 formation in Acinetobacter outside healthcare settings, which somehow increase the 
310 inflow of carriers into hospitals. This hypothesis is supported by increasing evidence that 
311 traits such as antibiotic resistance, biofilm formation and twitching motility can be 
312 thermoregulated in Acinetobacter [28,29]. The organism also adapts rapidly to 
313 temperature shift (from room temperature to 37ºC) and to availability of nutrients 
314 (from starvation to food availability), conditions easily found in new patients [30]. The 
315 community-associated (rather than healthcare-associated) origins of the increased 
316 incidence of Acinetobacter during summer or warmer months is supported by our 
317 finding of a persisting seasonal pattern when we looked at data from studies performed 
318 solely in ICUs, where climate conditions are largely artificial and stable. An investigation 
Page 16 of 76Clinical Microbiology and Infection
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
16
319 in 73 German ICUs revealed temperature-associated variation in Acinetobacter 
320 incidence despite that 83% of the units were air-conditioned during the entire study 
321 period [22]. The hypothesis of community-associated origins may be supported further 
322 by observations of polyclonal increase in Acinetobacter in summer/warmer months; 
323 however, we identified only one study that provided relevant evidence by examining the 
324 molecular heterogeneity of the isolates [26]. 
325 On the other hand, strictly community origins of incidence peaks in 
326 Acinetobacter infections are difficult to justify in light of our findings. We were able to 
327 extract 27 series of monthly data from reviewed studies, which produced a similar 
328 seasonal pattern irrespective of whether the origin of infections was associated with the 
329 community (n=3), the hospital (n=11) or a mixture of the two (n=13). Moreover, 
330 Acinetobacter is characterised by multidrug resistance, which is highly clonal in nature 
331 and a proxy of nosocomial origin. Only two studies attempted to examine seasonal 
332 variation in relation to the antimicrobial susceptibility of Acinetobacter isolates and 
333 produced conflicting results. In a single-centre study in the USA, significantly more non-
334 MDR A. baumannii cases were identified in warm months than in cold months, but a 
335 similar pattern was not observed for MDR cases [7]. In contrast, a single-centre in Brazil 
336 noted a stronger association of temperature with imipenem-resistant than with 
337 imipenem-susceptible strains of A. baumannii [8]. The possibility of differential variation 
338 depending on antimicrobial susceptibility should be addressed in future studies. Future 
339 research should also consider competing explanations based on non-weather-related 
340 seasonal factors such as understaffing associated with summer vacations, changes in 
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341 adherence to isolation precautions, or obtaining clinical cultures at different frequencies 
342 in summer. Empirical evidence for such associations is limited but appears to suggest 
343 that understaffing and bed occupancy rates correlate with the spread of hospital-
344 acquired infections [31]. Therefore, different mechanisms might explain the seasonal 
345 flow of Acinetobacter inside and outside the hospital and future explanatory studies 
346 should emphasize on clearly distinguishing between hospital-acquired and community-
347 acquired cases. 
348 We did not identify different seasonality between studies that included all types 
349 of infections combined and those that included Acinetobacter bacteraemia only. 
350 However, the current literature has not examined other infection types and we cannot 
351 exclude the possibility that seasonal variation might depend on the site of infection. It is 
352 not unreasonable, for example, to expect that pneumonias might peak during the colder 
353 months. Similarly, we did not identify differences between studies that examined 
354 colonization in conjunction with infection and those that examined infection only. 
355 However, only one study assessed colonization only and we cannot exclude the 
356 possibility of a difference in seasonal variation between Acinetobacter infections and 
357 colonizations. This would provide further insight into potential mechanisms underlying 
358 seasonality [32]. A time lag between seasonal peaks in colonization compared to 
359 infection would support the role of seasonal factors on Acinetobacter transmission and 
360 colonization. Seasonality in infection but not colonization would indicate that seasonal 
361 factors somehow affect host susceptibility to progression from colonization to infection 
362 [32]. These scenarios require validation in future studies.
Page 18 of 76Clinical Microbiology and Infection
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
18
363 In common with other reviews of the seasonality of infectious diseases 
364 [11,32,33], we identified that the bulk of the literature on the topic lacks robust 
365 statistical methodology. Graphical inspection or direct numerical comparison of 
366 Acinetobacter incidence over discrete calendar seasons were dominant approaches in 
367 assessing seasonality. However, aggregation of cases by calendar season may result in 
368 loss of information if infection occurrences have other periodicity (e.g. biannual) [11,33]. 
369 Direct comparison between discrete time intervals is limited by the inability to compare 
370 more than two intervals at once [11]. The geometrical model is outperformed by 
371 Poisson regression when estimating the magnitude of seasonal variation [34]. Therefore, 
372 time-series regression models should be preferred when studying the seasonality of 
373 infectious diseases [11,33]. However, appropriate regression modelling was utilized in 
374 only 4 (16%) of reviewed studies and this should be kept in mind when interpreting 
375 results from individual studies. 
376 The potential for publication bias should be considered because 40% of the 
377 reviewed studies were not performed with the primary objective of assessing 
378 seasonality. We should thus assess the possibility of a bias towards reporting results 
379 whenever seasonality was observed and not reporting them when no such seasonal 
380 variation was seen [32]. Our findings oppose this possibility because seasonality was 
381 reported in the great majority (13/15; 87%) of studies that assessed it as a primary 
382 objective, compared with half (5/10; 50%) of those that included seasonality as a non-
383 specific objective. Moreover, the seasonal pattern in Acinetobacter incidence remained 
384 consistent when we examined pooled standardised data in relation to seasonality 
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385 objective (primary v. secondary) and persisted under different data weights accounting 
386 for study size and overall quality rating. 
387 Individual studies reported Acinetobacter incidence with different metrics and 
388 we utilized z-scores to standardize the data across studies. This enabled us to examine 
389 consistency or robustness of the same seasonal pattern under different conditions by 
390 graphically comparing standardized data pooled across distinct subgroups. However, 
391 standardization masks the amplitude between the peak and the trough in disease 
392 incidence. Moreover, we did not attempt to estimate the magnitude or intensity of the 
393 seasonal effect that may vary substantially in different settings. Therefore, our analysis 
394 supports global consistency in the seasonal pattern of Acinetobacter, not a global 
395 magnitude of the seasonal effect. Another important consideration in interpreting our 
396 findings is that most data come from North America and Europe – regions with 
397 temperate climate and similar income level and health care infrastructure. Fewer 
398 studies were from tropical or sub-tropical zones in the southern hemisphere, almost all 
399 South American studies were done in Brazil and there was no data from Africa, which is 
400 a considerable gap in available information from those regions.
401
402 Conclusions
403
404 This systematic assessment of the literature suggests that the occurrence of 
405 Acinetobacter infections in hospitalised patients is characterised by a robust global 
406 seasonal pattern with an incidence peak in summer/warmer months and an incidence 
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407 trough in winter/colder months. This merits attention when designing or evaluating 
408 strategies for infection prevention and control in hospitals. We hope that our evaluation 
409 of the current evidence will prompt future investigations into the seasonality of 
410 Acinetobacter infections to elucidate the mechanisms underlying the phenomenon.
411
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Table I Characteristics of studies included in the review
Study Location Data source Design* Data 
Collection
Duration 
(mm/yyyy)
Follow-up 
(months)
No.  of 
cases**
Seasonality 
objective
Method Quality 
rating (%) $
Caldeira et al, 2015 
[12]
Sao Paulo, Brazil 1 teaching hospital (450 
beds)
Case-
series
Retr. 01/2005 - 
12/2010
72 177 Primary Comp. 82
Christie et al, 1995 
[26]
Connecticut , 
USA
1 tertiary-care hospital (770 
beds)
Case-
series
Pros. 01/1990 - 
12/1992
36 320 Primary Comp. 82
da Silveira et al, 2018 
[8]
Sao Paulo, Brazil 1 teaching hospital (335 
beds)
Case-
series
Retr. 01/2006 -
12/2017
144 1207 Primary GLM/TS 91
Davis et al, 2014 [18] Darwin , 
Australia
1 tertiary referral hospital 
(350 beds)
Case-
series
Pros. 01/1997 -
12/2012
192 41 Secondary Gmodel 82
Eber et al, 2011 [19] All USA The Surveillance Network, 
132 hospitals
Cohort Pros. 01/1999 -
09/2006
93 7618 Primary GLM/TS 100
Fillaux et al, 2006 [27] Toulouse, 
France
1 university hospital (1000 
beds)
Case-
series
Retr. 01/2000 -
12/2003
48 791 Secondary Comp. 73
Fortaleza et al, 2014 
[13]
Sao Paulo, Brazil 1 teaching hospital (450 
beds)
Case-
series
Retr. 01/2005 -
12/2010
72 177 Primary GLM/TS 91
Fukuta et al, 2012 [7] Pittsburg, USA 1 university hospital Case-
series
Retr. 05/2000 -
04/2011
132 1476 Primary Comp. 73
Gales et al, 2001 [17] Canada, USA, 
Argentina, 
Chile, Colombia, 
Mexico, Brazil, 
Venezuela
46 sentinel hospitals (28 in 
the USA, 8 in Canada, 10 in 
Latin America)
Case-
series
Pros. 01/1997 -
12/1999
36 261 Primary Graph 73
Gerner-Smidt, 1987 
[35]
Odense, 
Denmark
1 ICU (12 beds) Cohort Retr. 01/1984 -
12/1985
24 111 Secondary Comp. 73
Iqbal Hossain et al, 
1998 [36]
Dhaka, 
Bangladesh
International Centre for 
Diarrhoeal Disease Research
Cohort Retr. 01/1994 -
12/1994
12 138 Secondary Comp. 45
Kim et al, 2018 [15] Gyeonggido, 
Korea
1 community hospital (742 
beds)
Case-
series
Retr. 01/2006 -
12/2015
120 3520 Primary Comp. 82
Kolonitsiou et al, 
2017 [14]
Patra, Greece 1 university hospital (770 
beds)
Cohort Retr. 01/2011 -
12/2013
36 151 Primary Comp. 73
Lastoria et al, 2014 
[23]
Sao Paulo, Brazil 1 teaching hospital (450 
beds),
Cohort Retr. 01/2005 -
12/2010
72 na Secondary Graph 55
McDonald et al, 1999 
[25]
All USA National Nosocomial 
Infections Surveillance 
Cohort Pros. 01/1987 -
12/1996
120 3447 Primary Comp. 82
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System, ICU patients in 253 
hospitals
Morfin-Otero et al, 
2013 [37]
Guadalajara, 
Mexico
1 tertiary care teaching 
hospital (1,000 beds)
Case-
series
Retr. 01/1999 -
12/2011
156 3680 Secondary Graph 73
Papadimitriou-
Olivgeris et al, 2017 
[24]
Patra, Greece 1 university hospital, ICU (13 
beds)
Cohort Retr. 01/2010 -
12/2015
72 129 Secondary Graph 73
Perencevich et al, 
2008 [20]
Maryland, USA 1 tertiary care hospital (669 
beds)
Cohort Pros. 01/1998 -
12/2005
96 1444 Primary GLM/TS 100
Porter et al, 2013 [38] Nakhon 
Phanom  & Sa 
Kaeo, Thailand
20 hospitals Case-
series
Pros. 05/2005 -
12/2008
44 72 Secondary Graph 64
Retailliau et al, 1979 
[39]
All USA National Nosocomial 
Infections System, 81 
hospitals
Case-
series
Pros. 07/1974 54 1372 Primary Graph 91
Rodrigues et al, 2019 
[21]
Sao Paulo, Brazil 1 teaching hospital (450 
beds)
Case-
series
Retr. 07/2012 48 116 Primary Comp. 91
Schwab et al, 2014 
[22]
All Germany SARI Surveillance System, 73 
ICUs in 41 hospitals
Cohort Pros. 01/2001 144 3067 Primary Comp. 100
Seifert et al, 1994 [40] Cologne, 
Germany
4 ICUs in a university 
hospital (800 beds)
Case-
series
Pros. 01/1991 12 189 Secondary Graph 64
Siau et al, 1996 [16] Hong-Kong 1 tertiary care hospital 
(1350 beds)
Case-
series
Retr. 01/1990 59 7475 Primary Graph 91
Smego, 1985 [41] West Virginia, 
USA
1 university hospital (450 
beds)
Case-
series
Retr. 01/1979 60 27 Secondary Graph 73
ICU, intensive care unit; Retr., retrospective; Pros., prospective; Comp., direct comparison of incidence frequencies between discrete calendar periods; 
Graph, graphical inspections of incidence frequency over time; Gmodel, geometrical model; GLM/TS, generalised linear model or time series regression. 
* With regard to assessing seasonality, longitudinal studies with strictly-outcome based sampling (i.e. only patients infected or colonized by Acinetobacter) 
were labelled “case series”. Longitudinal studies that sampled from the pool of hospitalized patients were labelled “cohort” studies.
** Overall number of infections or colonizations recorded during the study period.
$  Based on the percentage of fulfilled applicable criteria in accordance with the Quality Assessment Tool for Observational Cohort and Cross-Sectional 
Studies [10]
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Table II Monthly incidence of Acinetobacter infection (27 data series) retrieved from 21 studies 
   Study Incidence measure Sub-group Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Peak 
Season$
Christie et al, 
1995 [26]
Avg monthly proportion (%) of 
inpatients with BSI by A. 
baumannii *
- 6.5 6.5 4.7 4.7 4.7 14.6 14.6 14.6 7.7 7.7 7.7 6.5 Summer
Davis et al, 2014 
[18]
Cumulative monthly count of 
community-onset pneumonias 
caused by Acinetobacter spp.*
- 6 3 5 3 2 2 0 0 3 4 2 11 Summer
Eber et al, 2011 
[19]
Avg monthly number of BSIs by 
Acinetobacter spp.* 
- 0.5 0.46 0.51 0.49 0.62 0.64 0.79 0.675 0.78 0.725 0.62 0.57 Autumn
Fillaux et al, 
2006 [27]
Avg monthly proportion (%)  of 
A. baumannii clinical isolates
- 10.7 7.2 5.5 4.7 6.4 6.0 8.5 11.8 11.3 10.2 9.6 8.0 Autumn
Not MDR 32 26 30 36 39 47 97 121 100 63 47 54 SummerFukuta et al, 
2012 [7] 
Cumulative monthly count of 
Acinetobacter spp isolates* MDR 108 62 69 64 64 40 62 55 49 64 63 84 Winter
Canada & USA 12 11 1 8 5 12 15 8 11 20 9 13 AutumnGales et al, 
2001 [17]
Cumulative monthly count of 
BSIs due to Acinetobacter spp.* Latin America 11 13 6 9 6 11 15 17 7 16 13 11 Winter
Gerner-Smidt, 
1987 [35]
Avg quarterly proportion (%) of 
A. calcoaceticus colonizations 
over all ICU admissions
- 6.4 6.4 6.4 6.2 6.2 6.2 7.0 7.0 7.0 5.4 5.4 5.4 Summer
Iqbal Hossain et 
al, 1998 [36]
Monthly proportion (%) of 
inpatients with BSI by 
Acinetobacter spp.
- 2.8 2.8 2.8 2.3 2.3 2.3 2.4 2.4 2.4 1.3 1.3 1.3 Spring
COI 9.9 11.2 9.1 11.3 10.5 11 12.2 18.1 14.6 9.9 10.6 7.6 SummerKim et al, 2018 
[15]
Avg monthly proportion of 
Acinetobacter spp. clinical 
isolates per 1,000 patients
HAI 10.7 7.9 9 8.9 8.9 8.4 8.7 9.2 11.1 9 8.5 12.6 Winter
Lastoria et al, 
2014 [23]
Avg monthly rate of BSI by A. 
baumannii per 10,000 patient-
days *
- 2.40 2.61 1.44 2.19 3.24 5.08 1.79 1.92 2.40 2.03 2.60 1.75 Winter
A. baumannii 4.15 4.68 3.63 3.71 3.22 4.77 6.09 7.08 6.29 5.48 4.74 4.03 SummerMcDonald et al, 
1999 [25]
Avg monthly rate of infections 
per 10,000 patient-days in ICU* Acinetobacter 
spp.
0.53 0.29 0.86 1.17 1.13 1.12 1.60 1.29 1.51 1.19 1.06 0.94 Summer
Morfin-Otero et 
al, 2013 [37]
Avg. monthly count of A. 
baumannii clinical isolates*
- 246.3 246.3 246.3 340.7 340.7 340.7 341.3 341.3 341.3 298.3 298.3 298.3 Summer
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Papadimitriou-
Olivgeris et al, 
2017 [24]
Avg monthly rate of BSI by A. 
baumannii per 1,000 ICU-days*
- 7.74 3.54 3.63 5.13 5.6 8.73 2.35 9.26 3.77 4.91 3.14 3.51 Summer
Perencevich et 
al, 2008 [20]
Cumulative monthly count of A. 
baumannii clinical isolates*
- 114 100 108 112 111 131 128 162 128 127 114 111 Summer
HAI 5 3 7 4 2 4 4 5 3 1 2 0 SpringPorter et al, 
2013 [38]
Cumulative monthly count of 
patients with BSI by 
Acinetobacter spp.*
COI 0 1 3 4 0 8 5 3 4 0 1 3 Spring
Retailliau et al, 
1979 [39]
Avg. monthly count of 
infections by A. calcoaceticus*
- 27.5 23.9 23.6 28.4 31.1 32.5 46.9 49.9 37.6 37.4 26.4 22.6 Summer
Rodrigues et al, 
2019 [21]
Avg monthly count of hospital-
acquired BSIs by A. baumannii
- 10.7 10.7 10.7 10.7 10.7 7.0 7.0 7.0 10.3 10.3 10.3 10.7 Summer
Schwab et al, 
2014 [22]
Avg monthly rate of A. 
baumannii clinical isolates per 
1,000 patient-days in ICU*
- 1.05 1.39 1.44 1.36 1.40 1.61 2.07 1.76 1.43 1.49 1.25 1.15 Summer
Seifert et al, 
1994 [40]
Monthly count of ICU patients 
with clinical culture positive for 
A. baumannii *
- 24 14 14 11 19 22 13 16 15 16 13 12 Summer
ICU  patients 194 176 172 155 172 166 230 186 197 209 300 178 AutumnSiau et al, 1996 
[16]
Cumulative monthly count of 
Acinetobacter clinical isolates * Ward patients 518 491 567 594 614 657 810 792 757 745 685 519 Summer
Smego, 1985 
[41]
Cumulative monthly count of 
patients with blood culture 
positive for A. calcoaceticus *
- 3 1 3 2 0 4 7 1 3 1 1 1 Summer
Avg, average; BSI, bloodstream infection; ICU, intensive-care unit; MDR, multi-drug resistant; COI, community onset infection; HAI, hospital-acquired 
infection.
* Data extracted from graph(s).
$ Peak season was defined as the season for which the sum of monthly incidence data was highest. Season are reported in accordance to hemisphere (e.g., 
summer is defined as June–August in the northern hemisphere and December–February in the southern hemisphere).
Page 32 of 76Clinical Microbiology and Infection
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
For Peer Review
32
FIGURE CAPTIONS
Figure 1. PRISMA flow diagram of the literature search conducted on 23rd October 2018 
to identify longitudinal epidemiological studies investigating seasonal variation in the 
incidence of infection caused by Acinetobacter species in hospitalized patients.
Figure 2. Graphical assessment of monthly incidence of Acinetobacter infection in 
hospitalized patients using 27 data series retrieved from 21 studies. Data were adjusted 
by six months in data series from the southern hemisphere (i.e. January = M7). Panel (a) 
weighting schemes were based on follow-up time (weight-1), overall number of 
infections (weight-2), composite product of follow-up time and number of infections 
(weight-3) and overall quality rating of each study (weight-4). The composite weight-3 
was used in panels (b)-(h). n, number of data series; BSI, bloodstream infection; PNU, 
pneumonia; COI/CAI, community-onset or community-acquired infection; HAI, hospital-
acquired infection; MIX, not distinguishing between different types.
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Supplementary Data
Appendix A. Search strategy
Database: EMBASE
Host: OVID  
Data Parameters: <1974 to 2018 October 23>
Date Searched: OCTOBER 23rd, 2018  
Hits: 177
# Searches Results
1 season*.mp. [mp=tx, bt, ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq] 193001
2 Acinetobacter baumannii.mp. [mp=tx, bt, ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq] 13453
3  "Acinetobacter".mp. [mp=tx, bt, ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq] 26443
4 Acinetobacter infections.mp. [mp=tx, bt, ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq] 310
5 seasonal pattern.mp. [mp=tx, bt, ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq] 2941
6 1 or 5 (193001) 193001
7 2 or 3 or 4 26443
8 6 and 7 177
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed 
Citations, Daily and Versions(R) 
Host: OVID  
Data Parameters: <1946 to October 23, 2018>
Date Searched: OCTOBER 23rd, 2018  
Hits: 127
# Searches Results
1 Acinetobacter baumannii.mp. or *Acinetobacter/ or *Acinetobacter baumannii/ or 
*Acinetobacter Infections/
10108
2  "Acinetobacter".mp. or ACINETOBACTER BAUMANNII/ or ACINETOBACTER/ or 
ACINETOBACTER CALCOACETICUS/ or ACINETOBACTER INFECTIONS/
15974
3 seasons.mp. or SEASONS/ 112894
4 SEASONS/ or season*.mp. ( 189938
5 Seasons/ or seasonal pattern.mp. 98375
6 1 or 2 15974
7 3 or 4 or 5 189938
8 6 and 7 127
Database: SCOPUS  
Data Parameters: <from inception to October 23, 2018>
Date Searched: OCTOBER 23rd, 2018  
Hits: 64
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# Searches Results
(TITLE-ABS-KEY((ACINETOBACTER AND BAUMANNII) OR (ACINETOBACTER) OR 
(ACINETOBACTER AND INFECTIONS)) OR TITLE-ABS-KEY (*ACINETOBACTER*)) AND 
(TITLE-ABS-KEY (SEASONS) OR (*SEASON)) AND NOT INDEX (MEDLINE) AND (LIMIT-TO 
(LANGUAGE,”ENGLISH”)) AND (LIMIT-TO (EXACTKEYWORD,“ACINETOBACTER”) OR 
LIMIT-TO (EXACTKEYWORD,“HUMAN”) OR LIMIT-TO (EXACTKEYWORD, “HUMANS”) 
OR LIMIT-TO (EXACTKEYWORD,”ACINETOBACTER BAUMANNII”))
64
Database: WEB OF SCIENCE
Data Parameters: <from inception to October 23, 2018>
Date Searched: OCTOBER 23rd, 2018  
Hits: 55
# Searches Results
1 TI=(ACINETOBACTER BAUMANNII/OR ACINETOBACTER/ OR ACINETOBACTER 
INFECTIONS)
Timespan=All years
Search language=English
14,779
2 TS=(ACINETOBACTER)
Timespan=All years
Search language=English
38,321
3 TI=(SEASON*/OR SEASONAL PATTERN)
Timespan=All years
Search language=English
193,548
4 #2 OR#1
Timespan=All years
Search language=English
38,321
5 #4 AND #3
Timespan=All years
Search language=English
55
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Appendix B. Excluded studies with reasons
Study 
identification
Title DOI Reason for exclusion
Adams D et al., 
2011
Investigation and management of an A. Baumannii outbreak 
in ICU
10.12968/bjon.2011.20.3.140 Outbreak report 
Al Masoudi et 
al., 2013
Incidence and prevalence of Acinetobacter baumannii in 
king fahd general hospital, Saudi Arabia
ISSN:1097-8135 Less than 12 months follow-up
Brahmi et al., 
2007
Epidemiology and risk factors for colonization and infection 
by Acinetobacter baumannii in an ICU in Tunisia, where this 
pathogen is endemic
10.1007/s10156-007-0557-0 Outbreak report
Chu YW et al Skin carriage of Acinetobacters in Hong Kong  jcm.asm.org/content/37/9/2962 Not reporting the incidence of Acinetobacter 
spp. infection or colonization.
Freeman et al., 
2009
Emerging evidence for seasonality of gram-negative 
bacterial infections
10.1086/597506 Commentary article. Not a longitudinal 
observational study. Not reporting the incidence 
of Acinetobacter spp. infection or colonization.
Herruzo et al., 
2004
Two consecutive outbreaks of Acinetobacter baumannii 1-a 
in a burn Intensive Care Unit for adults 
10.1016/j.burns.2004.01.008 Outbreak report
Hurley et al., 
2016
Worldwide variation in incidence of Acinetobacter 
associated ventilator associated pneumonia: a meta-
regression.
10.1186/s12879-016-1921-4 Not a longitudinal observational study. Not 
reporting the incidence of Acinetobacter spp. 
infection or colonization.
Mc Donald et 
al., 1998
Outbreak of Acinetobacter spp. bloodstream infections in a 
nursery associated with contaminated aerosols and air 
conditioners.
10.1097/00006454-199808000-
00011
Outbreak report
Munoz-Price et 
al., 2008
Acinetobacter infection 10.1056/NEJMra070741 Literature review. Not a longitudinal 
observational study
Ramphal et al Acinetobacter calcoaceticus variety anitratus: An increasing 
nosocomial problem.
10.1097/00000441-197901000-
00007
Could not retrieve full text
Schloesser et al., 
1990 
An Outbreak of Acinetobacter calcoaceticus Infection in a 
Neonatal Care Unit 
10.1007/BF01643394 Outbreak report
Schwab et al., 
2009
Summer season in the incidence of Gram-negative bacteria 
in ICUs
NA Conference abstract for which the published 
paper has been included in the review.
Seifert et al., 
1995
Nosocomial bacteremia due to Acinetobacter baumannii: 
Clinical features, epidemiology, and predictors of mortality
10.1097/00005792-199511000-
00004
Not reporting the incidence of Acinetobacter 
spp. infection or colonization.
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Smith et al., 
1979
Seasonal incidence of Acinetobacter infection 10.1093/infdis/140.2.275 Commentary. Not a longitudinal observational 
study.
Wisplinghoff et 
al., 2000
Nosocomial Bloodstream Infections Caused by Acinetobacter 
Species in United States Hospitals: Clinical Features, 
Molecular Epidemiology, and Antimicrobial Susceptibility
10.1086/314040 Not reporting the incidence of Acinetobacter 
spp. infection or colonization.
Yallew et al., 
2016
Point prevalence of hospital-acquired infections in two 
teaching hospitals of Amhara region in Ethiopia
10.2147/DHPS.S107344 Not longitudinal, less than 12 months follow-up
Zhang et al., 
2014
Epidemiological investigation on respiratory diseases in 1300 
children, in Jinan, Shandong
cma.j.issn.0254-6450.2014.11.022 Not in English language
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Appendix C. Critical appraisal of the quality of reviewed studies
Critical appraisal of study quality was based on the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. We utilized 11 
of 14 criteria that were applicable in the context of this review as shown in Table C1. All criteria were applied in accordance with the guidelines 
developed by the authors of the tool with the additional considerations and/or modifications shown in Table C1. A summary of our quality 
appraisal of reviewed studies is presented in Table C2. To obtain a crude sense of overall study quality, we calculated the percentage of fully 
fulfilled criteria for each study (i.e. percentage of “yes” responses to applicable criteria). 
Table C1. Criteria in the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies and modifications in the current review
No. Criterion Modification or additional consideration
Q1. Was the research question or objective in this paper clearly 
stated?
Assessed in relation to seasonality objective. Set to “Yes” only in studies that had a 
specific primary objective of assessing seasonal variation in the incidence of 
Acinetobacter infection.
Q2. Was the study population clearly specified and defined? Set to “Yes” in studies that included a clear statement or description of their target 
population irrespective of whether a summary presentation of patient demographics 
was presented or not. An example of a clear statement for the target population would 
be “Inpatients with a clinical culture positive for A. baumannii collected after day 3 of 
hospital admission.”
Q3. Was the participation rate of eligible persons at least 50%? Set to “No” only when there were legitimate reasons to expect that the study 
methodology or implementation would lead to exclusion of a substantial proportion of 
eligible patients in the target population.
Q4. Were inclusion and exclusion criteria for being in the study 
prespecified and applied uniformly to all participants?
-
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Q5. Was a sample size justification, power description, or variance 
and effect estimates provided?
Set to “Yes” if any of the following applied: (a) clear justification of sample size in 
accordance with the tool guidelines, or (b) large effective sample size of at least 10 
cases per month of follow up, or (c) reported low p-values for differences or trends (e.g. 
in Edward’s test for seasonality).
Q6. For the analyses in this paper, were the exposure(s) of interest 
measured prior to the outcome(s) being measured?
The exposure of interest was taken to be calendar season or any other discrete time 
period. The outcome of interest was the occurrence of Acinetobacter infection. All 
studies examined the association between exposure and outcome longitudinally. 
Therefore, Criterion Q6 was not applicable in this review.
Q7. Was the timeframe sufficient so that one could reasonably 
expect to see an association between exposure and outcome if 
it existed?
Eligibility criteria required at least 12 months of follow-up, so that at least a single 
comparison between seasons could be performed. Obviously, studies with repetition 
over several years would be more likely to detect true seasonality. Criterion Q7 was set 
to “Yes” for studies having at least 2 years of follow-up (i.e. at least two repetitions).
Q8. For exposures that can vary in amount or level, did the study 
examine different levels of the exposure as related to the 
outcome (e.g., categories of exposure, or exposure measured 
as continuous variable)?
The exposure of interest was taken to be calendar season or any other discrete time 
period. Therefore, Criterion Q8 was not applicable in this review.
Q9. Were the exposure measures (independent variables) clearly 
defined, valid, reliable, and implemented consistently across 
all study participants?
-
Q10. Was the exposure(s) assessed more than once over time? Set to “No” for studies having less than 1 year of follow-up and for those that 
performed 2-group comparisons of incidence data (e.g. summer v. winter). It was set to 
“Yes” when the data were examined longitudinally for at least 2 years of follow-up and 
a formal assessment of seasonality was included.
Q11. Were the outcome measures (dependent variables) clearly 
defined, valid, reliable, and implemented consistently across 
all study participants?
-
Q12. Were the outcome assessors blinded to the exposure status of 
participants?
Q12 was not applicable in this review.
Q13. Was loss to follow-up after baseline 20% or less? None of the studies reported loss to follow-up. Criterion Q13 was set to “No” only when 
there were legitimate reasons to expect that the study methodology or implementation 
would lead to substantial losses to follow-up. 
Q14. Were key potential confounding variables measured and 
adjusted statistically for their impact on the relationship 
between exposure(s) and outcome(s)?
This criterion was set to “Yes” for studies that utilised regression models to adjust for 
variation in climate parameters and/or other risk factors. 
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Table C2. Summary of the critical appraisal of the quality of reviewed studies
Study Q1 Q2 Q3 Q4 Q5 Q7 Q9 Q10 Q11 Q13 Q14 “Y” 
count
“Y” 
percent (%)
Caldeira et al, 2015 Y Y Y Y N Y Y N Y Y Y 9 82
Christie et al, 1995 Y Y Y Y Y Y Y N Y Y N 9 82
da Silveira et al, 2018 Y Y Y Y N Y Y Y Y Y Y 10 91
Davis et al, 2014 Ν Y Y Y Y Y Y Y Y Y N 9 82
Eber et al, 2011 Y Y Y Y Y Y Y Y Y Y Y 11 100
Fillaux et al, 2006 N Y Y Y Y Y Y N Y Y N 8 73
Fortaleza et al, 2014 Y Y Y Y N Y Y Y Y Y Y 10 91
Fukuta et al, 2012 Y Y Y Y N Y Y N Y Y N 8 73
Gales et al, 2001 Y Y Y Y N Y Y N Y Y N 8 73
Gerner-Smidt, 1987 N Y Y Y N Y Y Y Y Y N 8 73
Iqbal Hossain et al, 1998 Ν CD CD Y Y N Y N Y Y N 5 45
Kim et al, 2018 Y Y Y Y Y Y Y N Y Y N 9 82
Kolonitsiou et al, 2017 Y N Y Y N Y Y Y Y Y N 8 73
Lastoria et al, 2014 N Y Y Y N Y N N Y Y N 6 55
McDonald et al, 1999 Y Y Y Y Y Y Y N Y Y N 9 82
Morfin-Otero et al, 2013 N Y Y Y Y Y Y N Y Y N 8 73
Papadimitriou-Olivgeris et al, 2017 N Y Y Y N Y Y Y Y Y N 8 73
Perencevich et al, 2008 Y Y Y Y Y Y Y Y Y Y Y 11 100
Porter et al, 2013 N Y Y Y N Y Y N Y Y N 7 64
Retailliau et al, 1979 Y Y Y Y Y Y Y Y Y Y N 10 91
Rodrigues et al, 2019 Y Y Y Y N Y Y Y Y Y Y 10 91
Schwab et al, 2014 Y Y Y Y Y Y Y Y Y Y Y 11 100
Seifert et al, 1994 N Y Y Y Y N Y N Y Y N 7 64
Siau et al, 1996 Y Y Y Y Y Y Y Y Y Y N 10 91
Smego, 1985 N Y Y Y N Y Y Y Y Y N 8 73
Y, Yes; N, No; CD, cannot determine.
Page 74 of 76Clinical Microbiology and Infection
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
For Peer Review
PRISMA 2009 Checklist
Section/topic # Checklist item Reported on page # 
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number. 
2-3
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 4
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS). 
4 (lines 72-76)
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number. 
5 (lines 81-83)
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale. 
5, 6 (lines 97-118)
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched. 
5 (lines 85-94)
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated. 
5 (lines 85-94) + 
Appendix A
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis). 
5, 6 (lines 97-118)
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators. 
6,7 (lines 120-131) 
+ Appendices B, C
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made. 
6,7 (lines 120-131) 
+ Appendix C
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data 
synthesis. 
7, 8 (lines 141-151)
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 7 (lines 134-145)
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Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis. 
7 (lines 134-145)
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies). 
8 (lines 147-157)
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified. 
NA
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram. 
8 (lines 162-163), + 
Figure 1 + 
Appendix B
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations. 
8,9 (lines 164-182) 
+ Table I
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 9,10 (lines 184-
196) + Appendix C
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
(a) Tables I and II, 
Figure 2.
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 10-11 + Figure 2 
(descriptive 
analysis of data 
pooled across 
subgroups)
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 9, 10 + Appendix C, 
Figure 2
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 
Item 16]). 
NA
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers). 
14 – 17
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias). 
18-19
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research. 
19-20
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funders for the systematic review. 
20
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